Private Advisor Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-300
Closed -$771 2270
2023
Q3
$771 Buy
+300
New +$80.2K ﹤0.01% 2265

Other funds holding BIIB

Private Advisor Group's BIIB Position: Q2 2026 in Review

Private Advisor Group reduced its Biogen (BIIB) stake by 46% in Q2 2026, selling an estimated $409K and leaving 2,510 shares worth $542K. The position accounts for ﹤0.01% of the portfolio, ranked #1743.

Private Advisor Group first reported a position in BIIB in Q4 2013 and has held it in 51 quarters since. The position peaked at $12M in Q3 2021. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Private Advisor Group held 2,510 shares of Biogen worth $542K as of Q2 2026.
  • Private Advisor Group sold 2,139 Biogen shares in Q2 2026, an estimated $409K.
  • Biogen made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1743 holding.
  • Private Advisor Group first reported a position in Biogen in Q4 2013 and has held it in 51 quarters since.
  • Private Advisor Group's Biogen position peaked at $12M in Q3 2021.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.